We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Sees Rise in Applications for Pediatric Use
For the third year in a row, pharmaceutical companies are filing more proposals with the European Medicines Agency’s pediatric committee seeking approval for the development of drugs for children.